[HTML][HTML] The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): a regression-based …
A Mauguen, RK Grewal, F Augensen… - European Journal of …, 2023 - Springer
Purpose To introduce a biomarker-based dosimetry method for the rational selection of a
treatment activity for patients undergoing radioactive iodine 131I therapy (RAI) for metastatic …
treatment activity for patients undergoing radioactive iodine 131I therapy (RAI) for metastatic …
[HTML][HTML] First Strike personalized predictive radioiodine prescription for inoperable metastatic differentiated thyroid cancer
YH Kao - Asia Oceania Journal of Nuclear Medicine and Biology, 2023 - ncbi.nlm.nih.gov
Objective (s): The traditional practice of empiric radioiodine (I-131) prescription is
scientifically obsolete and inappropriate for inoperable metastatic differentiated thyroid …
scientifically obsolete and inappropriate for inoperable metastatic differentiated thyroid …
[PDF][PDF] Reply LTE, Single time point tumour dosimetry assuming normal distribution of tumour kinetics
We thank the authors for their careful reading of our paper and for illustrating the value of
single-timepoint imaging in the practical implementation of patient-specific dosimetry for …
single-timepoint imaging in the practical implementation of patient-specific dosimetry for …
A simplified general schema for rapid single time-point marrow predictive dosimetry
YH Kao - Nuclear Medicine Communications, 2023 - journals.lww.com
The red marrow is often the dose-limiting organ in systemic radionuclide therapy. However,
multi-time-point personalised predictive dosimetry is resource intensive and impractical for …
multi-time-point personalised predictive dosimetry is resource intensive and impractical for …
[HTML][HTML] Rapid predictive dosimetry for Second Strike prescription based on whole body radioiodine kinetics in differentiated thyroid cancer
YH Kao - Asia Oceania Journal of Nuclear Medicine and Biology, 2024 - ncbi.nlm.nih.gov
Objective (s): In systemic radionuclide therapy such as radioiodine (I-131) for differentiated
thyroid cancer, post-therapy dosimetry is essential to verify pre-therapy predictions, which in …
thyroid cancer, post-therapy dosimetry is essential to verify pre-therapy predictions, which in …
Toward precision biomarker RAI therapy of well-differentiated thyroid cancer: linking administered radioactivity (MBq) to a prescribed lesion radiation-absorbed dose …
A Mauguen, R Grewal, F Augensen, M Abusamra… - 2022 - researchsquare.com
Purpose To introduce a biomarker-based dosimetry method for radioactive iodine 131 I
therapy (RAI) of metastatic differentiated thyroid cancer (mDTC), adapted to the underlying …
therapy (RAI) of metastatic differentiated thyroid cancer (mDTC), adapted to the underlying …